期刊文献+

慢性阻塞性肺疾病与冠心病共病研究进展 被引量:5

Research Progress on Comorbidity of Chronic Obstructive Pulmonary Disease and Coronary Heart Disease
在线阅读 下载PDF
导出
摘要 慢性阻塞性肺疾病(COPD)与冠心病均是严重危害人类健康的常见慢性病且二者关系密切。研究表明,COPD患者发生冠心病的风险是非COPD患者的1.24倍,而冠心病患者COPD发病率为18%~41%,与单纯COPD或单纯冠心病患者相比,COPD与冠心病共病患者预后更差。本文主要综述了COPD与冠心病共病的危险因素、发病机制、预防及治疗,旨在提高临床医生对COPD与冠心病共病的诊疗水平。 Chronic obstructive pulmonary disease(COPD)and coronary heart disease are common chronic diseases that seriously endanger human health and are closely related.Studies have shown that the risk of coronary heart disease in COPD patients is 1.24 times than that of non-COPD patients,and the incidence of COPD in patients with coronary heart disease is 18%-41%.Compared with patients with simple COPD or simple coronary heart disease,the prognosis of patients with comorbidity of COPD and coronary heart disease is worse.This article reviews the risk factors,pathogenesis,prevention,and treatment of comorbidity of COPD and coronary heart disease,in order to improve the diagnosis and treatment of COPD and coronary heart disease by clinicians.
作者 刘洪如 武冬民 李娜 王林霞 王耀勇 LIU Hongru;WU Dongmin;LI Na;WANG Linxia;WANG Yaoyong(Fenyang College of Shanxi Medical University,Fenyang 032200,China;Department of Respiratory and Critical Care Medicine,Fenyang Hospital of Shanxi Province,Fenyang 032200,China)
出处 《实用心脑肺血管病杂志》 2023年第4期126-131,共6页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
基金 山西省卫健委医学重点科研攻关专项(2020XM30)。
关键词 慢性阻塞性肺疾病 冠心病 共病 综述 Chronic obstructive pulmonary disease Coronary heart disease Comorbidity Review
  • 相关文献

参考文献5

二级参考文献26

  • 1慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志(电子版),2014,6(2):67-80. 被引量:2078
  • 2肖建,杜春玲.慢性阻塞性肺疾病病因及发病机制研究进展[J].中国老年学杂志,2014,34(11):3191-3194. 被引量:166
  • 3黄元铸.心率与冠心病关系的研究进展[J].中华心血管病杂志,2006,34(6):574-576. 被引量:50
  • 4Salazar J, Olivar LC, Ramos E, et al. Dysfunctional high-density lipoprotein: an innovative target for proteomics and lipidomics[J[. Cholesterol, 2015, 2015: 296417. DOI: 10.1155/2015/296417.
  • 5King VL, Thompson J, Tannock LR. Serum amyloid A in atherosclerosis[J]. Curt Opin Lipidol, 2011, 22(4): 302-307. DOI: 10.1097/MOL.0b013e3283488c39.
  • 6Khera AV, Cuchel M, de la Llera-Moya M, et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis[J]. N Engl J Med, 2011, 364(2): 127-135. DOI: 10.1056/NEJMoa- 1001689.
  • 7Duffy D, Radcr DJ. Update on strategies to increase HDL quantity and function[J]. Nat Rev Cardiol, 2009, 6(7): 455-463. DO/: 10. 1038/nrcardio.2009.94.
  • 8Deeb SS, Takata K, Peng RL, et al. A splice-junction mutation responsible for familial apolipoprotein A-II deficiency[J]. Am J Hum Genet, 1990, 46(4): 822-827.
  • 9Wang Y, Sawashita J, Qian J, et al. ApoA-1 deficiency in mice is associated with redistribution of apoA-II and aggravated AApoA ][ amyloidosis[J]. J Lipid Res, 2011, 52(8): 1461-1470. DOI: 10.1194/ jlr.M013235.
  • 10Yan J, Fu X, Ge F, et al. Cross-seeding and cross-competition in mouse apolipoprotein A-II amyloid fibrils and protein A amyloid fibrilS[J]. Am J Pathol, 2007, 171(I): 172-180.

共引文献219

同被引文献72

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部